Marie‐Christine Pérault‐Pochat

Incidence of hospital admissions due to adverse drug reactions in <scp>F</scp>rance: the <scp>EMIR</scp> study

Anne Bénard‐Laribière, Ghada Miremont‐Salamé, Marie‐Christine Pérault‐Pochat et al. · Fundamental and Clinical Pharmacology · 2014 · 132 citations

Hospital Admissions, Pharmacotherapy, Adverse Drug Reaction +20

Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer

Marion Allouchery, Thomas Lombard, M. Martin et al. · Journal for ImmunoTherapy of Cancer · 2020 · 117 citations · Full text

Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France

Chantal Barin‐Le Guellec, Claire Lafay‐Chebassier, Isabelle Ingrand et al. · European Journal of Cancer · 2019 · 62 citations · Full text

Medicine, Metronomic Therapy, Pharmacology +9

Drugs and dilated cardiomyopathies: a case/noncase study in the French PharmacoVigilance Database

Guillaume Montastruc, Sylvie Favrelière, Agnès Sommet et al. · British Journal of Clinical Pharmacology · 2009 · 48 citations · Full text

Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross‐sectional study

Marie‐Laure Laroche, Marie‐Christine Pérault‐Pochat, Isabelle Ingrand et al. · Pharmacoepidemiology and Drug Safety · 2013 · 45 citations